Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
Co-development of precision RNA therapeutics for inherited hearing loss treatmentView original content to download multimedia:https://www.prnewswire.co.uk/news-releases/rznomics-enters-global-licensing-agreement-with-eli-lilly-for-rna-editing-therapeutics-302456854.html
en | boerse | 67965699 |
